People with rare diseases get 'unequal treatment' from 'inflexible' NHS drug regulator, warns report

A study by MAP BioPharma found only 13 per cent of rare disease medicines made it through The National Institute for Health and Care Excellence (NICE) assessments.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news